The U.S. Justice Department said Aug. 12 that Azizulah “Aziz” Kamali, MD, and his practice, Aziz Kamali, MD Inc., admitted to submitting claims to Medicare for surgically implanted neurostimulator devices even though they did not perform surgery or implant neurostimulators. Instead, they taped a disposable electroacupuncture device called a “Stivax” to their patients’ ears.
Stivax devices do not require surgical implantation and are not reimbursable by Medicare, according to a Justice Department news release.
Dr. Kamali and his practice also admitted to paying a marketing company a percentage of the reimbursements they received from Medicare for billing implantable neurostimulators, in return for the marketing company arranging for and recommending that patients order the Stivax devices from them, according to the news release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.